Evidence map›Paper›PMID 25439055›Full record

Trial reportBMC psychiatry2014

A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness.

Rudolf Uher, Jill Cumby, Lynn E MacKenzie, Jessica Morash-Conway, Jacqueline M Glover, Alice Aylott, Lukas Propper, Sabina Abidi, Alexa Bagnell, Barbara Pavlova and 6 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Interventions for prodromal stage of psychosis.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Rudolf UherCapital District Health Authority, Halifax, Nova Scotia, Canada. uher@dal.ca.
Jill CumbyCapital District Health Authority, Halifax, Nova Scotia, Canada. Jill.Cumby@cdha.nshealth.ca.
Lynn E MacKenzieCapital District Health Authority, Halifax, Nova Scotia, Canada. Lynn.MacKenzie@cdha.nshealth.ca.
Jessica Morash-ConwayCapital District Health Authority, Halifax, Nova Scotia, Canada. Jessica.Morash@cdha.nshealth.ca.
Jacqueline M GloverCapital District Health Authority, Halifax, Nova Scotia, Canada. Jacqueline.Glover@cdha.nshealth.ca.
Alice AylottCapital District Health Authority, Halifax, Nova Scotia, Canada. alice.aylott@dal.ca.
Lukas PropperIWK Health Centre, Halifax, Nova Scotia, Canada. Lukas.Propper@iwk.nshealth.ca.
Sabina AbidiIWK Health Centre, Halifax, Nova Scotia, Canada. Sabina.Abidi@iwk.nshealth.ca.
Alexa BagnellIWK Health Centre, Halifax, Nova Scotia, Canada. alexa.bagnell@iwk.nshealth.ca.
Barbara PavlovaCapital District Health Authority, Halifax, Nova Scotia, Canada. Barbara.Pavlova@cdha.nshealth.ca.
Tomas HajekCapital District Health Authority, Halifax, Nova Scotia, Canada. tomas.hajek@dal.ca.
David LovasIWK Health Centre, Halifax, Nova Scotia, Canada. David.Lovas@iwk.nshealth.ca.
Kathleen PajerIWK Health Centre, Halifax, Nova Scotia, Canada. pajerk@gmail.com.
William GardnerIWK Health Centre, Halifax, Nova Scotia, Canada. william.p.gardner@gmail.com.
Adrian LevyDepartment of Public Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada. adrian.levy@dal.ca.
Martin AldaCapital District Health Authority, Halifax, Nova Scotia, Canada. MALDA@Dal.Ca.
Capital District Health Authority · CAIzaak Walton Killam Health Centre · CADalhousie University · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundSevere mental illness (SMI), including schizophrenia, bipolar disorder and severe depression, is responsible for a substantial proportion of disability in the population. This article describes the aims and design of a research study that takes a novel approach to targeted prevention of SMI. It is based on the rationale that early developmental antecedents to SMI are likely to be more malleable than fully developed mood or psychotic disorders and that low-risk interventions targeting antecedents may reduce the risk of SMI. METHODS/

designFamilies Overcoming Risks and Building Opportunities for Well-being (FORBOW) is an accelerated cohort study that includes a large proportion of offspring of parents with SMI and embeds intervention trials in a cohort multiple randomized controlled trial (cmRCT) design. Antecedents are conditions of the individual that are distressing but not severely impairing, predict SMI with moderate-to-large effect sizes and precede the onset of SMI by at least several years. FORBOW focuses on the following antecedents: affective lability, anxiety, psychotic-like experiences, basic symptoms, sleep problems, somatic symptoms, cannabis use and cognitive delay. Enrolment of offspring over a broad age range (0 to 21 years) will allow researchers to draw conclusions on a longer developmental period from a study of shorter duration. Annual assessments cover a full range of psychopathology, cognitive abilities, eligibility criteria for interventions and outcomes. Pre-emptive early interventions (PEI) will include skill training for parents of younger children and courses in emotional well-being skills based on cognitive behavioural therapy for older children and youth. A sample enriched for familial risk of SMI will enhance statistical power for testing the efficacy of PEI. DISCUSSION: FORBOW offers a platform for efficient and unbiased testing of interventions selected according to best available evidence. Since few differences exist between familial and 'sporadic' SMI, the same interventions are likely to be effective in the general population. Comparison of short-term efficacy of PEI on antecedents and the long term efficacy for preventing the onset of SMI will provide an experimental test of the etiological role of antecedents in the development of SMI.

Indexed as

FamilySeverity of Illness IndexAdolescentChildChild of Impaired ParentsChild, PreschoolCognitive Behavioral TherapyCohort StudiesEarly Medical InterventionFemaleFollow-Up StudiesHumansInfantMaleMental DisordersRisk Factors

Identifiers

PMID25439055
PMCPMC4267051
OpenAlexW2151944801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.